Surginex
PrivateLast Round
Series B
Mar 28, 2024
Total Funding Raised
$9.69M
Company Overview
Surginex operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Series B round in March 2024.
Surginex is a biotechnology company that develops AI-based drug discovery platforms and next-generation lipid nanoparticle (LNP) technology for targeted drug delivery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Surginex Comparables
Compare Surginex with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genevant Sciences | 84% | |
| Hopewell Therapeutics | 82% | |
| Acuitas Therapeutics | 79% |
For institutional investors. Book with your work email.
Surginex Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 28, 2024 | ||||
| Series A | Oct 18, 2021 |
For institutional investors. Book with your work email.
Surginex Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hana Ventures | Series B |
| POSCO Capital | Series B |
| K-Net Investment Partners | Series A |
| Kiwoom Investment | Series B |
| LSK Investment | Series B |
| Kiwoom Investment | Series B |
| Partners Investment | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 28, 2024
$6.3M round with participation from Kiwoom Investment and POSCO Technology Investment.
For institutional investors. Book with your work email.
Surginex Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Surginex's valuation, stock price, and market status.
Is Surginex a public or private company?
Surginex is a private company.
What is the current stock price of Surginex?
Surginex is a private company, so its shares have no public market price. Caplight tracks Surginex's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Surginex worth (valuation)?
Valuation information for Surginex is not publicly available.
Can I buy Surginex stock?
Surginex shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Surginex's last funding round?
Surginex's most recent funding round was Series B on March 28, 2024.
Who are the main investors in Surginex?
Key investors in Surginex include Hana Ventures, POSCO Capital, K-Net Investment Partners, Kiwoom Investment, LSK Investment.
Will Surginex IPO soon?
No public IPO plans have been announced for Surginex.
How can I track Surginex secondary market activity?
Caplight tracks bids, offers, and trades in Surginex's shares on secondary markets.